HeartWorks

About

We build, test, and deliver new therapies to cure congenital heart defects, allowing families to live full, enriching lives.

Our Goal

Treating children & adults with CHD using novel stemcell therapies that delay the need for
a heart transplant forever.

HeartWorks has designed a first-of-its-kind platform that brings together physicians, 
scientists, and engineers to find and develop treatments for the most severe forms 
of congenital heart defects (CHD) to further advance research in genetics, stem cell biology, clinical trials, and cell-based manufacturing.


We get treatments out of the lab and into clinical trials to be conducted simultaneously in collaboration with a consortium of world-class medical institutions. Our vision is that our therapies will become a cure so children and adults born with CHD will no longer
have to live with CHD.

“The world’s largest consortium committed to curing congenital heart defects. Together with our partners, the FDA and CHD families, we are moving at the speed of trust.”